Natural killer cell therapy for liver cancer
Part of Cancer, Digestive system clinical trials.
This study tests an experimental therapy using your own natural killer cells to fight liver cancer. It may be an option if you have a specific stage of liver cancer and are generally in good health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 60 years old.
- You have been diagnosed with liver cancer at stage BCLC B or C.
- You are able to care for yourself (Karnofsky score of 70 or higher).
- Your blood counts, liver function, and kidney function are within normal ranges.
- You have not had an organ transplant or stem cell therapy before.
- You do not have other cancers or serious conditions like high blood pressure, heart disease, or active infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a custom immune-cell treatment made to target a marker (GPC3) found on some liver cancers. It’s for adults with advanced HCC whose cancer has worsened after standard treatment or who couldn’t tolerate it.
This study is testing whether combining targeted therapy with immunotherapy (or using two immunotherapies together) can help people with liver cancer that cannot be surgically removed. The goal is to understand how well these treatments work and how they affect biomarkers (signals in your body that show treatment response).
This trial studies an experimental cell therapy that uses your own immune cells collected from your tumor to fight the cancer. It aims to see if this approach is safe and effective for advanced liver cancer that has progressed after standard treatments.
This Phase 2 study tests an immune-cell treatment (activated T lymphocytes) given after your liver cancer tumor has been fully removed. It aims to improve safety and reduce the chance of the cancer coming back in people with early-stage hepatocellular carcinoma.
This trial tests a new treatment using your own immune cells (tumor-infiltrating lymphocytes) to fight advanced liver cancer. It is for people whose cancer has progressed after at least two standard treatments and who have tumors that can be biopsied to grow these cells.
This study tests whether a type of immune cell therapy called CIK cells is safe and feasible for people with early-stage liver cancer who have just had their tumor removed. It aims to see if this treatment can help prevent the cancer from coming back.
Hear when a new Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.